Biography
Dr. Huixiao Hong is a senior Scientist at National Center for Toxicological Research (NCTR), US Food and Drug Administration (FDA), Arkansas, USA, working on the scientific bases for regulatory application and development of genomics biomarkers. Before joining the FDA, he was the Manager of Bioinformatics Division at Z-Tech, an ICFI company, at NCTR. He held a Research Scientist position at Sumitomo Chemical Company in Japan. He was a visiting scientist at National Cancer Institute (NCI) at National Institutes of Health (NIH). He was also an Associated Professor and the Director of Laboratory of Computational Chemistry at Nanjing University in China. He published more than 140 scientific papers and served as Editor-in-Chief, Executive Editor and Editorial Board member for more than 10 peer-reviewed journals and as reviewer for more than 20 peer-reviewed journals. He received his Ph.D. from Nanjing University in China and did post-doctoral research at Maxwell Institute in Leeds University in England.
Research Interest
Biomarker
Biography
Anthia A. Zammit LL.B, LL.D counsels clients on regulatory law and global data privacy matters primarily in the healthcare; life sciences; biotechnology; pharmaceutical; food; and chemical industries. She represents a diverse client-base encompassing Swiss; French; German; UK; Belgian; Dutch; Israeli; Maltese, Latin American; and U.S. companies. Anthia served as legal counsel to the Healthcare Business Section of the Malta Chamber of Commerce, Enterprise, and Industry, and as a member of the European Patients’ Forum (EPF) Policy Advisory Committee. She previously worked in the Office of the CEO of the Medicines Authority (the “Maltese FDAâ€). Anthia’s profile was enhanced by her role in global supply chain expansion of private and publicly-listed companies in established and emerging markets, including the EU, U.S., and Latin America. Anthia is experienced in contract negotiation; medicinal product launches; drug and vaccine licensing; regulatory affairs; regulatory compliance; good manufacturing practice; good distribution practice; pharmacovigilance; pricing & reimbursement; and marketing. She is regularly a keynote speaker at high-level conferences on invitation of the European Commission. Anthia received an LL.B (Bachelor of Laws) and an LL.D (Doctor of Laws) from the University of Malta. Her doctoral dissertation Pharmaceutical Law in the EU and USA: The Impact on Public Health and the Pharmaceutical Industry, earned her the European Commission's and World Health Organisation’s European Health Forum Gastein Scholarship. Anthia is admitted to the practice of law in the Republic of Malta (a member state of the European Union), and is certified as a Legal Consultant by the Supreme Court of the State of New York, U.S. http://www.anthiazammit.com
Research Interest
Pharmaceutical Law, Drug Law, Health Law, Public Health, EU Healthcare, Pharmaceutical Industry, Regulatory Affairs, Pharmaceutical Licensing, Medicine Registration, Pharmaceutical Manufacturing, Pharma Marketing, Life Sciences, Biotech Industry, Malta Pharmacy, Malta Health, Medicinal Products, Product Launches, Supply Chain, Generic Drugs, Innovative Drugs, European Union, United States, Latin America.
Biography
Dr. Carmen Popescu got her B.S. degree in Physics and Ph.D. in Biophysics at University of Bucharest, Romania. She is a Senior Project Coordinator at Roquette America Inc. and Adjunct Associate Professor with University of Illinois at Chicago. Roosevelt University, University of Tennessee, University of Maryland.She has published over 120 research papers, book chapters and presentations on classic and new drug delivery dosage for small and large molecules. Additionally she is a reviewer for the International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Pharma & Pharmaceutical Science and an active member of AAPS and CRS.
Research Interest
Classic dosage forms (liquid, semi-solid, and solid dosage forms formulation) as well as drug delivery systems (microparticles, nanoparticles, liposomes, niozome, etc.) for small and large molecules.